Physician

Shahin Pourrabbani, M.D.

According to 2025 Medicare claims, Shahin Pourrabbani, M.D. (NPI: 1013226877) practices vascular surgery in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is VASCULAR & THORACIC ASSOCIATES OF LOS ANGELES (NPI: 1295706901; TIN: 954205704) and primary practice location at 90247-4013.

Pourrabbani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 174 traditional Medicare patients, billed 2,605 HCPCS/CPT codes, and received $2,665,677 in Medicare payments. The top billing code was 37229 (Removal of plaque in artery of leg, initial vessel). Part D data shows 29 prescription claims totaling $11,871 in drug costs, led by Clopidogrel (Clopidogrel Bisulfate). Open Payments data shows 32 records totaling $16,504. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $26,193 to $2,665,677. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,109 to $11,871. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $26,193 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $104,229 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $81,333 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $45,063 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,194,311 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,440,679 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $834,194 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,157,674 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,287,733 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,665,677 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201575234$26,193
2016224826$104,229
2017149591$81,333
2018101259$45,063
20191651,022$1,194,311
20201151,448$1,440,679
202198871$834,194
20222122,236$1,157,674
20231832,050$1,287,733
20241742,605$2,665,677

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.2K$12K2016 Drug cost: $1,109 (USD; Tot_Drug_Cst)2017 Drug cost: $761 (USD; Tot_Drug_Cst)2018 Drug cost: $2,625 (USD; Tot_Drug_Cst)2019 Drug cost: $6,543 (USD; Tot_Drug_Cst)2020 Drug cost: $7,448 (USD; Tot_Drug_Cst)2021 Drug cost: $12,355 (USD; Tot_Drug_Cst)2022 Drug cost: $10,972 (USD; Tot_Drug_Cst)2023 Drug cost: $11,473 (USD; Tot_Drug_Cst)2024 Drug cost: $11,871 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20163972$1,109
20173972$761
20182861$2,625
201942112$6,543
20203595$7,448
20213287$12,355
20222946$10,972
20231937$11,473
2024N/R29$11,871

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
37229Removal of plaque in artery of leg, initial vessel5298$7,650
37252Ultrasound evaluation of blood vessel with review by radiologist, initial vessel5299$853
36246Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch54102$372
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more75113$107
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5666$78

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ClopidogrelClopidogrel Bisulfate13810$197

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$16,504AngioDynamics, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shahin Pourrabbani, M.D.?

Tedicare shows public-source Medicare data for Shahin Pourrabbani, M.D. (NPI 1013226877), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shahin Pourrabbani, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shahin Pourrabbani, M.D.?

Shahin Pourrabbani, M.D. is linked to VASCULAR & THORACIC ASSOCIATES OF LOS ANGELES (billing NPI 1295706901) in the available physician profile data.

Does Shahin Pourrabbani, M.D. have Open Payments data?

Shahin Pourrabbani, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.